hemophilia
Blood Cell Traits Linked to Individual Loci, Polygenic Contributors in International Studies
Two new papers have identified thousands of genetic loci with ties to more than two-dozen blood cell traits in individuals from up to five ancestry groups.
The free genetic testing program has amassed genetic data and samples from more than 5,000 patients that researchers can now apply to access.
The firm also said it aims to soon begin human studies for its hepatic porphyria treatment ALN-AS1 and to select a development candidate for its program in primary hyperoxaluria type 1.
The therapy is the company's first to feature an optimized version of its GalNAc conjugate delivery technology.
NEW YORK (GenomeWeb) – As Phase I testing of its hemophilia therapy ALN-AT3 continues, Alnylam Pharmaceuticals is setting its sights broadly for the program, taking aim at both patients receiving standard medical care as well as those who have become refractory to such treatment, company official
Oct 9, 2014
Aug 7, 2014
Jan 23, 2014
Oct 31, 2013
Oct 9, 2013
Aug 22, 2013
Aug 15, 2013
Aug 15, 2013
Jul 3, 2013
May 9, 2013
Jan 10, 2013
Dec 13, 2012
Jul 12, 2012
Jan 12, 2012